Montserrat Mesegue Meda
Pediatric leukemia and hematopoiesis
The researcher Montserrat Mesegué graduated in Medicine in 2008 from the Autonomous University of Barcelona. She has been a specialist in Pediatrics since 2013 and later completed her master's degree in Pediatric Hematology at the SJD Barcelona Children’s Hospital, completed in 2015.
She is currently completing her doctoral thesis linked to the University of Barcelona: Study of clinical and biological factors associated with toxicity in the treatment of pediatric acute lymphoblastic leukemia, led by Dr. Mireia Camós and Dra. Susana Rives.
- Mesegue Meda M, Alonso-Saladrigues A, Pérez-Jaume S, Comes-Escoda A, José Luis Dapena Díaz, Faura A, Conde Cuevas N, Català-Temprano A, Ruiz-Llobet A, Zapico-Muñiz E, Camós-Guijosa M and Rives-Sola S Lower incidence of clinical allergy with PEG-asparaginase upfront versus the sequential use of native E. coli asparaginase followed by PEG-ASP in pediatric patients with acute lymphoblastic leukemia. HEMATOL ONCOL . 39(5): 687-696.
- Berrueco R, Sebastián E, Maria Solsona Gadea, González de Pablo J, Ruiz-Llobet A, Mesegue Meda M, Gálvez E and Sevilla J Secondary immune thrombocytopenia in children: Characteristics and outcome of a large cohort from two Spanish centres. ACTA PAEDIATRICA . 110(6): 1952-1958.
- Vega-García N, Malatesta R, Estella-Aguado MC, Pérez-Jaume S, Esperanza-Cebollada E, Torrebadell-Burriel M, Català-Temprano A, Gassiot S, Berrueco R, Ruiz-Llobet A, Alonso-Saladrigues A, Mesegue Meda M, Pont-Martí S, Rives-Sola S and Camós-Guijosa M Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases. BRITISH JOURNAL OF HAEMATOLOGY . 182(4): 542-553.